India has long been a major player in the development and manufacturing of treatments, but more and more drugmakers are outsourcing the monitoring of on-the-market drugs to vendors in the country. As The Wall Street Journal reports, India's safety monitoring business has ballooned to $2 billion a year, employing about 15,000 people compared to just 300 in 2007. News